Skip to Main Content

Paper Details

Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Am J Kidney Dis
6
2023
AKI, Acute Kidney Injury, Tumor Necrosis Factor Receptor, acute kidney injury, heart failure, kidney disease, participants, patients, plasma samples, sTNFR1, sTNFR2, tumor necrosis factor receptor 1
Author NameAffiliation
Sherry G MansourYale University School of Medicine
Dennis G MoledinaYale University School of Medicine
Heather Thiessen-PhilbrookJohns Hopkins University
Pavan K BhatrajuKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
Edward D SiewVanderbilt University Medical Center
Amit X GargSchulich School of Medicine and Dentistry, Western University
Kathleen D LiuUniversity of California san francisco
Alan S GoUniversity of California, Kaiser Permanente Northern California
Nicholas M SelbyRoyal Derby Hospital, University of Nottingham
Chirag R ParikhJohns Hopkins University
  • 1 - 12

Datasets

Release 1.2